A new vaccine called NicVax has recently been developed by Florida-based Nabi Biopharmaceuticals. The vaccine is used as a nicotine blocker to prevent and treat nicotine addiction. A clinical trial, held in both the US and the Netherlands, said that injections were safe and well tolerated. Now a Dutch organization STIVORO would like the Dutch government to add this vaccine to their vaccine program so it can be given to children as young as 9 years old.
Amazing...
Mickel
No comments:
Post a Comment